Important notice — please read
Before you continue
This website is intended solely for institutional investors, professional investors, and other eligible or qualified investors. By proceeding, you confirm that you fall within one of these categories under the laws of your jurisdiction of residence.
Nothing on this website constitutes, or should be construed as, an offer, invitation, solicitation, or recommendation to subscribe for, purchase, or otherwise deal in any securities, notes, or other financial instruments, in any jurisdiction.
Any securities referred to on this website have not been and will not be registered under the U.S. Securities Act of 1933 or the securities laws of any other jurisdiction. They are offered and sold only outside the United States to non-US persons in reliance on Regulation S, and within the European Union only to qualified investors / institutional investors as defined under the EU Prospectus Regulation. This website is not directed at, and must not be relied upon by, persons in the United States or in any jurisdiction where such distribution would be unlawful.
The information presented is for general information purposes only and does not constitute investment, legal, tax, or financial advice. Any offer of securities will be made solely on the basis of, and subject to the terms of, the relevant final terms, prospectus, or offering memorandum, which alone should be relied upon. Statements about future plans, targets, or issuance timelines are forward-looking and are not guarantees of outcome.
By clicking "I Accept," you confirm that you have read and understood this notice, that you are an eligible investor as described above, and that you agree to be bound by these terms for the duration of your visit to this website.
Investor Portal
The secure investor portal is being finalised and will provide KYC'd investors with access to factsheets, reporting, and deal rooms. To request early access or a demo, contact ir@sanguinetmc.com.